FAM90A11P

Across TCGA pan-cancer cohorts, FAM90A11P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated FAM90A11P data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher FAM90A11P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM90A11P expression acts as an unfavorable survival marker, although some lineages such as LIHC show a favorable association.

CHOL, ACC, and SKCM are the cancer types where FAM90A11P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.675	<.001	72	view →
ACC	DFS	Tertile	III,IV	0.010	0.458	<.001	63	view →
SKCM	DFS	Tertile	All	0.053	0.757	<.001	54	view →
LUSC	DFS	Tertile	III,IV	0.230	0.574	.004	36	view →
CESC	DFS	Tertile	II,III,IV	0.193	0.705	.045	18	view →
THCA	OS	Tertile	III,IV	0.747	0.934	.011	18	view →
BLCA	OS	Tertile	All	0.119	0.405	.034	12	view →
PCPG	OS	Tertile	All	0.904	1.000	.005	9	view →
LIHC	DFS	Tertile	III,IV	1.000	0.169	.044	9	view →
LGG	OS	Quartile	All	0.728	0.855	.025	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

FAM90A11P–CHOL (OS)

Open the CHOL breakdown →